Pharmacotherapeutic management of dementia across settings of care.
about
Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.Effect of medications on physical function and cognition in nursing home residents with dementiaChoosing wisely: prevalence and correlates of low-value health care services in the United States.A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.The diminished pipeline for medications to treat mental health and substance use disordersHow Prolific is Psychotropic Medicines Use in People with Dementia in Australia Within the Community Setting? A Retrospective Analysis.Prevalence and management of dementia in primary care practices with electronic medical records: a report from the Canadian Primary Care Sentinel Surveillance Network.Application of the European quality indicators for psychosocial dementia care in long-term care facilities in the Asia-Pacific region: a pilot study.Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes?Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand.Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up.Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study.Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).Re-evaluating psychotropic drug use across care settings.Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.
P2860
Q33604532-94E718A5-66C8-46DB-A6DD-66FAA4BD7153Q34103934-A51A7E8D-C67B-42FD-A765-A517FDC70873Q35040379-1D41F444-D8CA-44A5-B2D1-00E7CD08FF00Q36206447-53FF74BC-4423-4A0B-8A20-EA5D59122A95Q36677600-AD1706C4-E405-4F34-B679-314F4E6BA783Q36942933-6E93666C-3D4B-40CC-8503-45AF0B2BDCFCQ37066780-C43BB3BB-44B9-4D49-8F00-7C75CF2974CFQ38656554-C2D24D88-D338-4210-8506-AD966D2BF652Q38737187-8512E8E8-40A1-4C14-ADAF-63EA0055E1C6Q38836769-18865C9D-2536-4BF5-B4BE-774D8D95464FQ38860696-E6BA773D-306D-481C-8377-0D9145B9CDD2Q39961795-72FF9DD9-96C0-4A8D-9B59-49FEDBDC4B4FQ50206887-9009C75A-EB73-474E-98A9-7069678C3460Q50637315-30C3AA7B-06F9-4668-8002-B1E5E2BDF110Q50691493-7027F225-9003-4948-A9D7-A6182D8B1B38Q51737702-D37B0498-70FD-42E2-9B47-4C0C4009E1B7
P2860
Pharmacotherapeutic management of dementia across settings of care.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacotherapeutic management of dementia across settings of care.
@en
type
label
Pharmacotherapeutic management of dementia across settings of care.
@en
prefLabel
Pharmacotherapeutic management of dementia across settings of care.
@en
P2093
P2860
P356
P1476
Pharmacotherapeutic management of dementia across settings of care.
@en
P2093
Christine S Franey
Gail B Rattinger
Ilene H Zuckerman
Loreen D Walker
Mehmet Burcu
Pankdeep T Chhabra
Paul B Rosenberg
Sarah K Dutcher
P2860
P304
P356
10.1111/JGS.12210
P407
P577
2013-04-16T00:00:00Z